Chuanmiao Liu

Dr. Chuanmiao Liu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2023 in Heliyon
Verified
Journal Article
Open access
WZWen Zhao
Wen Zhao
MLMiao Lei
Miao Lei
JLJinfeng Li
Jinfeng Li
HZHailin Zhang
Hailin Zhang
HZHongkun Zhang
Hongkun Zhang
CLChuanmiao Liu
Chuanmiao Liu
This study aims to determine which cell death modes contribute most in the progression of cirrhosis and acute-on-chronic liver failure (ACLF), and to investigate whether Yes associated protein (YAP) affects the disease process by regulating cell death. 30C57BL/6 male mice were divided into five groups: control, carbon tetrachloride (CCl4)-induced liver fibrosis model, CCl4+verteporfin, CCl4+lipopolysaccharides (LPS) combined with the D-(+)-Galactosamine (LPS/D-GalN)-induced ACLF model, and ACLF + verteporfin. Patients with chronic hepatitis B (CHB), hepatitis B virus (HBV) related liver cirrhosis or ACLF were enrolled. Histology, immunohistochemistry, transmission electron microscopy, Western blot and ELISA were conducted to assess the roles of YAP and cell death in liver cirrhosis and ACLF, and to explore the effect of YAP inhibition on cell deaths. YAP was markedly increased in mice with liver fibrosis and ACLF, along with ferroptosis and necroptosis. Furthermore, YAP inhibition significantly suppressed fibrosis in CCl4-mediated liver fibrosis and ACLF-associated liver injury. Notably, CCl4 induced up-regulation of ACSL4 and RIPK3 and down-regulation of SLC7A11, key factors in ferroptosis and necroptosis. This was significantly abrogated by verteporfin treatment. Similar changes in ferroptosis and necroptosis were found in ACLF and ACLF + verteporfin groups. Consistent with the above findings in mice, we found that plasma YAP levels were gradually increased with the development of HBV-related liver fibrosis and ACLF. Ferroptosis and necroptosis are involved in the development of liver cirrhosis and ACLF. Inhibition of YAP improved liver fibrosis and liver damage in ACLF through a reduction in ferroptosis and necroptosis. Our findings may help better understanding the role of YAP in liver fibrosis and ACLF.

6 September 2022 in Journal of Cancer
Verified
Journal Article
Open access
LLLu Liu
Lu Liu
KYKangkang Yu
Kangkang Yu
CHChong Huang
Chong Huang
MHMeisi Huo
Meisi Huo
XLXiaoqi Li
Xiaoqi Li
JZJubo Zhang
Jubo Zhang
Background: Hepatocellular carcinoma (HCC) is the most common form of liver cancer, and significant sex disparities have been observed in HCC. We aim to explore the potential sex-biased mechanisms involved in hepatocarcinogenesis.

25 September 2025
Verified
Journal Article
Closed access
SWSiyuan Wang
Siyuan Wang
SLShihui Liu
Shihui Liu
HRHejing Ruan
Hejing Ruan
YCYuzhe Cheng
Yuzhe Cheng
YQYan Qiao
Yan Qiao
WZWen Zhao
Wen Zhao

1 January 2016 in World Chinese Journal of Digestology
Verified
Journal Article
Open access
XHXue Huang
Xue Huang
CLChuanmiao Liu
Chuanmiao Liu
SZShou-Song Zhao
Shou-Song Zhao
JZJiu-Fa Zhao
Jiu-Fa Zhao
CGChun-Ming Gao
Chun-Ming Gao
KXKui-Hua Xu
Kui-Hua Xu

1 September 2021
Verified
Journal Article
Closed access
SDShasha Dong
Shasha Dong
MHMin Huang
Min Huang
DLDongdong Li
Dongdong Li
YGYu Gao
Yu Gao
ZLZhenghong Li
Zhenghong Li
CLChuanmiao Liu
Chuanmiao Liu

1 October 2023
Verified
Journal Article
Closed access
WZWen Zhao
Wen Zhao
MLMiao Lei
Miao Lei
HZHailin Zhang
Hailin Zhang
JWJiawei Wang
Jiawei Wang
DLDongdong Li
Dongdong Li
CLChuanmiao Liu
Chuanmiao Liu